The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gausling Michael J since 2005.
The trader's CIK number is 1125761.
At the time of the last reporting, Gausling Michael J was the Director of Tabula Rasa Healthcare, Inc.. (stock ticker symbol TRHC).
Also see all insider trading activities at Tabula Rasa Healthcare, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2017 | TRHC | 0 | $0 | 1,988,000 | $51,389,798 | 0 | $0 |
2016 | TRHC | 8,000 | $96,000 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | KNBT | 4,500 | $62,870 | 0 | $0 | 0 | $0 |
2006 | KNBT | 2,000 | $31,788 | 0 | $0 | 0 | $0 |
2005 | KNBT | 1,000 | $16,250 | 0 | $0 | 0 | $0 |
1. Tabula Rasa Healthcare, Inc. (TRHC)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-12-08 | TRHC | Sale | 523,805 | 25.85 | 13,540,359 |
2017-12-11 | TRHC | Sale | 160,375 | 25.85 | 4,145,693 |
2017-12-08 | TRHC | Sale | 237,195 | 25.85 | 6,131,490 |
2017-12-11 | TRHC | Sale | 72,625 | 25.85 | 1,877,356 |
2017-12-08 | TRHC | Sale | 761,000 | 25.85 | 19,671,850 |
2017-12-11 | TRHC | Sale | 233,000 | 25.85 | 6,023,050 |
2016-10-04 | TRHC | Buy | 8,000 | 12.00 | 96,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-07-27 | KNBT | Buy | 2,000 | 12.92 | 25,840 |
2007-03-07 | KNBT | Buy | 2,500 | 14.81 | 37,030 |
2006-08-01 | KNBT | Buy | 1,000 | 15.90 | 15,898 |
2006-01-31 | KNBT | Buy | 1,000 | 15.89 | 15,890 |
2005-08-03 | KNBT | Buy | 1,000 | 16.25 | 16,250 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gausling Michael J (Director of Tabula Rasa Healthcare, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.